Newmark Group, INC. 13F Holdings Overview (1 Positions)
Newmark Group, INC.
CIK: 0001690680
Long-term holder
Total reported value
—
Reporting period: 2023-09-30 · Number of holdings: 1
NEWMARK GROUP, INC. disclosed 1 holdings in its latest 13F filing for the period ending 2023-09-30, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Position changes disclosed by Newmark Group, INC. for the quarter ending 2023-09-30, including ticker, issuer, weight change, shares change, and action
What is Newmark Group, INC. and what type of investor is it?
Newmark Group, INC. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2023-09-30), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Newmark Group, INC.'s largest equity positions?
Based on the latest 13F filing, Newmark Group, INC.'s top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Newmark Group, INC. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Newmark Group, INC. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Newmark Group, INC. focus on?
Sector breakdown data is not yet available for Newmark Group, INC.. Check back after the next 13F processing cycle.